Patients remain at the heart of the work we do every day. Patients’ health. Patients’ lives. Patients’ families and caregivers. They are what matters most to us, guiding us forward in our goal to deliver a completely different cancer therapy that could lengthen patient lives while maintaining their quality of life.
Since her glioblastoma diagnosis, Marleen Colosimo, a retired special education teacher, has learned to enjoy every day and to cope with the uncertainty of a life-threatening disease.
Martin Romero Sanchez, a glioblastoma patient, and his wife, Karma Punwasi, have found support by connecting with other brain cancer survivors and caregivers, along with young adults affected by cancer.
Our Device Support Specialists (DSSs) work one-on-one with patients — educating them about the device, and providing technical support and personal contact with Novocure. Learn more about Amy Luton, one of our DSSs in Texas.
In the face of his glioblastoma diagnosis, Michael Davies strives to maintain normalcy and continue his personal and professional pursuits of working in the entertainment industry, and writing and performing stand-up comedy.
clinical trialsOur mechanism of action is broadly applicable across a variety of solid tumors.
publicationsWe have more than 15 years of research and multiple peer-reviewed publications with pre-clinical data in 15 cancer types and clinical data in eight cancer types.
novocuretrial.comThe science of Tumor Treating Fields extends beyond glioblastoma. We are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.